Open to debate. The motion: there is a role for chronic treatment with PDE5-inhibitors

Eur Urol. 2006 Apr;49(4):749-53. doi: 10.1016/j.eururo.2006.01.044. Epub 2006 Feb 17.

Authors

Jeremy W Heaton¹, Dimitris Hatzichristou

Affiliation

¹ Dept Urology, Kingston General Hospital, Kingston, Ontario, Canada.

PMID: 16510235
DOI: 10.1016/j.eururo.2006.01.044

No abstract available

MeSH terms

Cardiovascular Diseases / drug therapy*
Erectile Dysfunction / drug therapy*
Humans
Male
Phosphodiesterase Inhibitors / adverse effects*
Phosphodiesterase Inhibitors / therapeutic use*

Substances

Phosphodiesterase Inhibitors